New Delhi, February 25 Drug firm Lupin announced on Wednesday that it has received approval from the US health regulator to market a generic medication to treat seizures.The Mumbai-based firm has received approval from the USFDA for its abbreviated new drug application (ANDA) for Brivaracetam...
anda
brivaracetam
briviact
bse
drug approval
generic medication
india
lupin
oralsolution
pharmaceutical industry
pharmaceutical sales
seizures
us market
usfda